Molecular dynamics of buspirone analogues interacting with the 5-HT1A and 5-HT2A serotonin receptors

被引:25
作者
Bronowska, A
Les, A
Chilmonczyk, Z
Filipek, S
Edvardsen, O
Ostensen, R
Sylte, I
机构
[1] Univ Tromso, Inst Med Biol, Dept Pharmacol, N-9037 Tromso, Norway
[2] Univ Warsaw, Dept Chem, PL-02093 Warsaw, Poland
[3] Pharmaceut Res Inst, PL-01793 Warsaw, Poland
[4] Drug Inst, Warsaw, Poland
[5] Univ Tromso, Inst Pharm, Dept Pharmacol, N-9037 Tromso, Norway
[6] Univ Tromso, Dept Phys, N-9037 Tromso, Norway
关键词
D O I
10.1016/S0968-0896(00)00307-2
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Three-dimensional (3-D) models of the human serotonin 5-HT1A and 5-HT2A receptors were constructed, energy refined. and used to study the interactions with a series of buspirone analogues. For both receptors, the calculations showed that the main interactions of the ligand imide moieties were with amino acids in transmembrane helix (TMH) 2 and 7. while the main interactions of the ligand aromatic moieties were with amino acids in TMH5, 6 and 7. Differences in binding site architecture in the region of highly conserved serine and tyrosine residues in TMH7 gave slightly different binding modes of the buspirone analogues at the 5-HT1A and 5-HT2A receptors. Molecular dynamics simulations of receptor-ligand interactions indicated that the buspirone analogues did not alter the interhelical hydrogen bonding patterns upon binding to the 5-HT2A receptor, while interhelical hydrogen bonds were broken and others were formed upon ligand binding to the 5-HT1A receptor, The ligand-induced changes in interhelical hydrogen bonding patterns of the 5-HT1A receptor were followed by rigid body movements of TMH2, 4 and 6 relative to each other and to the other TMHs, which may reflect the structural conversion into an active receptor structure. (C) 2001 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:881 / 895
页数:15
相关论文
共 46 条
[1]  
Almaula N, 1996, MOL PHARMACOL, V50, P34
[2]   Mixed anxiety and depression - Diagnosis and treatment options [J].
Bakish, D ;
Habib, R ;
Hooper, CL .
CNS DRUGS, 1998, 9 (04) :271-280
[3]   An alpha-carbon template for the transmembrane helices in the rhodopsin family of G-protein-coupled receptors [J].
Baldwin, JM ;
Schertler, GFX ;
Unger, VM .
JOURNAL OF MOLECULAR BIOLOGY, 1997, 272 (01) :144-164
[4]   THE PROBABLE ARRANGEMENT OF THE HELICES IN G-PROTEIN-COUPLED RECEPTORS [J].
BALDWIN, JM .
EMBO JOURNAL, 1993, 12 (04) :1693-1703
[5]   A review of central 5-HT receptors and their function [J].
Barnes, NM ;
Sharp, T .
NEUROPHARMACOLOGY, 1999, 38 (08) :1083-1152
[6]   ANTICONFLICT AND DISCRIMINATIVE STIMULUS EFFECTS OF THE 5-HT1A COMPOUNDS WY-47,846 AND WY-48,723 AND THE MIXED 5-HT1A AGONIST 5-HT2 ANTAGONIST WY-50,324 IN PIGEONS [J].
BARRETT, JE ;
ZHANG, L .
DRUG DEVELOPMENT RESEARCH, 1991, 24 (02) :179-188
[7]   Novel and selective 5-HT2C/2B receptor antagonists as potential anxiolytic agents:: Synthesis, quantitative structure-activity relationships, and molecular modeling of substituted 1-(3-pyridylcarbamoyl)indolines [J].
Bromidge, SM ;
Dabbs, S ;
Davies, DT ;
Duckworth, DM ;
Forbes, IT ;
Ham, P ;
Jones, GE ;
King, FD ;
Saunders, DV ;
Starr, S ;
Thewlis, KM ;
Wyman, PA ;
Blaney, FE ;
Naylor, CB ;
Bailey, F ;
Blackburn, TP ;
Holland, V ;
Kennett, GA ;
Riley, GJ ;
Wood, MD .
JOURNAL OF MEDICINAL CHEMISTRY, 1998, 41 (10) :1598-1612
[8]  
CHANDA PK, 1993, MOL PHARMACOL, V43, P516
[9]   Conformational flexibility of serotonin(1A) receptor ligands from crystallographic data. Updated model of the receptor pharmacophore [J].
Chilmonczyk, Z ;
SzelejewskaWozniakowska, A ;
Cybulski, J ;
Cybulski, M ;
Koziol, AE ;
Gdaniec, M .
ARCHIV DER PHARMAZIE, 1997, 330 (05) :146-160
[10]   BUSPIRONE ANALOGS AS LIGANDS OF THE 5-HT1A RECEPTOR .1. THE MOLECULAR-STRUCTURE OF BUSPIRONE AND ITS 2 ANALOGS [J].
CHILMONCZYK, Z ;
LES, A ;
WOZNIAKOWSKA, A ;
CYBULSKI, J ;
KOZIOL, AE ;
GDANIEC, M .
JOURNAL OF MEDICINAL CHEMISTRY, 1995, 38 (10) :1701-1710